Hisamitsu Pharmaceutical Co Inc 2023 Integrated Report
Company: Hisamitsu Pharmaceutical Co Inc
Sector: Manufacturing
Country: Japan
Year: 2023
Type: Integrated Report
Pages: 32
The report describes FY2022 progress on materiality and sustainability priorities, reports total Group CO~2~ emissions of 34,452 t, and highlights the Company's TCFD scenario analysis. It also reports 2,769 consolidated employees as of February 28, 2023.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.